Educational
Resources
Explore Ametris' educational resources to gain a deeper understanding of Digital Health Technologies in clinical trials.
Educational
Explore Ametris' educational resources to gain a deeper understanding of Digital Health Technologies in clinical trials.
Featured Resource
Ametris partnered with Johnson & Johnson Innovative Medicine to improve wearable adherence in the global Phase 3 LIBERTAS trial for a metastatic castration-sensitive prostate cancer (mCSPC) therapy. In this study, actigraphy devices were used for more than 12 months to continuously measure sleep quality and physical activity as objective proxies for hot flash burden.
No resources match your search. Try adjusting your filters.
Ready to accelerate your DHT strategy? Our experts can help. Schedule a meeting with a member of our Science Team to receive personalized guidance on maximizing the benefits of DHTs throughout the clinical development lifecycle.